GSE114492 GSE153671 KMT2D inhibition 5 v 11 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE114492_GSE153671_KMT2D inhibition_5_v_11_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE114492_GSE153671_KMT2D inhibition_5_v_11_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE114492_GSE153671_KMT2D inhibition_5_v_11_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE114492_GSE153671_KMT2D inhibition_5_v_11_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

DnaJ heat shock protein family (Hsp40) member A3

Gene

paternally expressed 10

Gene

regulator of cell cycle

Gene

brain abundant membrane attached signal protein 1

Gene

monoglyceride lipase

Gene

fatty acid binding protein 5

Gene

sortilin related receptor 1

Gene

serum/glucocorticoid regulated kinase 1

Gene

kynureninase

Gene

glutaminyl-peptide cyclotransferase

  • Gene

    DnaJ heat shock protein family (Hsp40) member A3


  • Gene

    paternally expressed 10


  • Gene

    regulator of cell cycle


  • Gene

    brain abundant membrane attached signal protein 1


  • Gene

    monoglyceride lipase


  • Gene

    fatty acid binding protein 5


  • Gene

    sortilin related receptor 1


  • Gene

    serum/glucocorticoid regulated kinase 1



  • Gene

    glutaminyl-peptide cyclotransferase

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.